About Downstream Processing
Downstream Processing refers to the recovery and purification of biosynthetic products, particularly pharmaceuticals. It is an essential step in the manufacture of pharmaceuticals such as antibiotics, hormones, antibodies, and vaccines. The purpose of downstream processing is to isolate, purify, and concentrate the previously synthesized drug substance or other product from the complex bulk matrix. Downstream processing is usually considered a specialized field in biochemical engineering.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
The companies are exploring the market by adopting expansions, investments, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to avail of competitive advantage through combined collaborations. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Downstream Processing market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Thermo Fisher Scientific Inc. (United States), GE Healthcare (United States), Sartorius Stedim Biotech S.A. (France), Merck Millipore (Germany), Danaher Corporation (United States), GlaxoSmithKline (United Kingdom), Finesse Solutions Inc. (United States) and Lonza Group (Switzerland) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are M Company (United Kingdom), Ferner PLC (India) and Others.
Segmentation Overview
AMA Research has segmented the market of Global Downstream Processing market by Type (Chromatography Columns and Resins, Filters, Membrane Adsorbers, Single-use Products and Other Products (Consumables and Accessories)), Application (Monoclonal Antibody Production, Vaccine Production, Insulin Production, Immunoglobulin Production, Erythropoietin Production and Others) and Region.
On the basis of geography, the market of Downstream Processing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Techniques, the sub-segment i.e. Purification will boost the Downstream Processing market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Biopharmaceutical Manufacturers will boost the Downstream Processing market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Growth in Use of Techniques and Technology
Market Growth Drivers:
Increasing Demand for Biopharmaceuticals, Rising Adoption of Single-use Technology in Bioprocessing and Expansion of Bioprocessing Capacity
Challenges:
Lack of Skilled Professionals
Restraints:
High Cost of Instruments
Opportunities:
Increased Demands for New Solutions, Process Optimization & Cost Reduction and Rising Innovation in the Biotechnology and Bioprocessing Sector
Market Leaders and their expansionary development strategies
In Mar 2019, Sartorius Stedim Biotech (SSB), a leading supplier for the biopharmaceutical industry, and Novasep based in Pompey, France, have entered into a collaboration agreement in the area of chromatography and single-use bioprocessing. Novasep provides various products and services to the life science industry, based on specialized technologies.
In October 2023, SCHOTT launched ViewCell for downstream processes.
Key Target Audience
Downstream Processing Providers, Vendors/Service Providers, Research and Consulting Firms, Biopharmaceutical Manufacturers, Manufacturing Organizations, Government Organisations and Others
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.